CNBX Pharmaceuticals Inc (CNBX)

[WallyWest]

They’re all different, but if you track their general performance against CNBX over the last year or so, you see a pretty good correlation, which suggests that this is more of a sector dynamic than something specific to CNBX. My personal opinion is that as investors became more circumspect, CNBX has traded more as a biotech play and less as a cannabis company. I would love to see the stock jump, but they’ll need news that can significantly affect their valuation for that to happen. In the meantime, I’m sure their past volatility has attracted shorters, so they’ll have some headwinds to break $1.00. If they can generate significant revenue, or if they announce something that will add significant net value, the shorters will move on to easier pickings.